The next generation of PDE4 inhibitors

被引：107

作者：

Huang, Z ^{[1
]}

Ducharme, Y ^{[1
]}

Macdonald, D ^{[1
]}

Robichaud, A ^{[1
]}

机构：

[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2001年 / 5卷 / 04期

关键词：

D O I：

10.1016/S1367-5931(00)00224-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A number of highly potent PDE4 inhibitors are being developed for the treatment of asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis and Crohn's disease. Cilomilast (Ariflo(TM), SB 207499, SmithKline Beecham), the most advanced member of the class in Phase III clinical trials, was reported to have a limited therapeutic window. Other inhibitors with improved profiles in preclinical models are entering into (or are in) clinical trials. The recent developments in understanding PDE4 catalysis, inhibitor binding and their emetic response should facilitate the design of the next generation of PDE4 inhibitors.

引用

页码：432 / 438

页数：7

共 97 条

[51] Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways -: A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells [J].

Liu, HG ;

Palmer, D ;

Jimmo, SL ;

Tilley, DG ;

Dunkerley, HA ;

Pang, SC ;

Maurice, DH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26615-26624

[52] Hunting the emesis and efficacy targets of PDE4 inhibitors:: Identification of the photoaffinity probe 8-(3-azidophenyl)-6-[(4-iodo-1H-1-imidazolyl)methyl]quinoline (APIIMQ) [J].

Macdonald, D ;

Perrier, H ;

Liu, S ;

Laliberté, F ;

Rasori, R ;

Robichaud, A ;

Masson, P ;

Huang, Z .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) :3820-3823

[53] ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases -: The involvement of COOH-terminal docking sites and NH2-terminal UCR regions [J].

MacKenzie, SJ ;

Baillie, GS ;

McPhee, I ;

Bolger, GB ;

Houslay, MD .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :16609-16617

[54] Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B [J].

Manning, CD ;

Burman, M ;

Christensen, SB ;

Cieslinski, LB ;

Essayan, DM ;

Grous, M ;

Torphy, TJ ;

Barnette, MS .

BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (07) :1393-1398

[55] Cyclic 3′,5′-nucleotide phosphodiesterases:: Potential targets for anticancer therapy [J].

Marko, D ;

Pahlke, G ;

Merz, KH ;

Eisenbrand, G .

CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (10) :944-948

[56] Induction of Apoptosis by an Inhibitor of cAMP-Specific PDE in Malignant Murine Carcinoma Cells Overexpressing PDE Activity in Comparison to Their Nonmalignant Counterparts [J].

Marko D. ;

Romanakis K. ;

Zankl H. ;

Fürstenberger G. ;

Steinbauer B. ;

Eisenbrand G. .

Cell Biochemistry and Biophysics, 1998, 28 (2-3) :75-101

[57] Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy [J].

Mehta, S ;

Liu, PP ;

Fitzgerald, FS ;

Allidina, YK ;

Bradley, TD .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (01) :128-134

[58] Desensitization of β2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by β2-agonists in guinea pig eosinophils [J].

Mio, M ;

Kirino, Y ;

Kamei, C .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (05) :896-903

[59] Phosphodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-α [J].

Miró, X ;

Casacuberta, JM ;

Gutiérrez-López, MD ;

de Landázuri, MO ;

Puigdomènech, P .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (02) :415-421

[60] The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I [J].

Napoletano, M ;

Norcini, G ;

Pellacini, F ;

Marchini, F ;

Morazzoni, G ;

Ferlenga, P ;

Pradella, L .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (19) :2235-2238

← 1 2 3 4 5 6 7 8 9 10 →